Samsung Biologics

Biologics development services from Samsung Biologics, including cell line development, IND filing support, CGMP manufacturing, and custom CMC solutions.

Samsung Biologics delivers CGMP biopharma manufacturing services - from drug substance to aseptic fill-finish. Scalable CDMO services for quality and speed.

Discover Samsung Biologics’ integrated GMP quality systems, quality control testing, regulatory affairs support, and cGMP compliance services. Expert biologics CDMO with digital QA/QC platforms.

The decision by any institution on the selected host cell line impacts the quality, cost of goods, and speed of the development process. Through this poster,

Accelerated tech transfer timelines are becoming increasingly desirable to support the development and manufacture of biologics that have the potential to add

Samsung Biologics established its articles of incorporation under the Commercial Act and publishes an annual corporate governance report.

The success or failure of a business is directly dependent on how well its supply chain operations are managed, and this is even more so for the pharmaceutic

Samsung Biologics offers brochures detailing its services and capabilities.

Explore Samsung Biologics’ Events page to find upcoming and previous webinars, conferences, and Newsroom event updates.

Samsung Breaks Ground for Biopharmaceutical PlantToday, the venture - Samsung Biologics - held a groundbreaking ceremony in the free economic zone at the port c

Samsung Biologics provides employee wellness benefits for staff and their families.

Samsung Biologics values its employees career development and provides systematic training opportunities to grow professionally.

Samsung Biologics employs over 100 global experts from 11 countries and has been recognized as a ‘Best Family-Friendly Management’ company.

John Rim, CEO of Samsung Biologics, leads the company’s mission to improve accessibility and quality of biomedicines globally.

Samsung Biologics introduces its key executives and their professional stories.

As the world s largest biomanufacturing site by capacity, Bio Campus I supports a broad spectrum of global pharmaceutical and biotech clients with comprehensive end-to-end CDMO services across diverse modalities and molecule types.

Samsung Biologics provides contract development, manufacturing, and biosafety testing services.

As a leading end-to-end service provider, Samsung Biologics has achieved a great number of milestones over the past decade.

Samsung Biologics offers solutions through its representatives for client inquiries.

Samsung Biologics is a leading global CDMO providing end-to-end biologics development, CGMP manufacturing, and aseptic fill/finish services for biopharma partners worldwide.